Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Leukotrienes and inflammation.

S D Brain1, T J Williams

  • 1Biosciences Division, King's College, London, U.K.

Pharmacology & Therapeutics
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Leukotrienes, inflammatory molecules derived from fatty acids, play key roles in conditions like asthma and arthritis. Inhibiting leukotriene generation and action offers potential as an anti-inflammatory therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Relevance of TRPA1 and TRPM8 channels as vascular sensors of cold in the cutaneous microvasculature.

Pflugers Archiv : European journal of physiology·2017
Same author

Evidence for physiological and pathological roles for sensory nerves in the microvasculature and skin.

Current research in translational medicine·2016
Same author

Calcitonin gene-related peptide: physiology and pathophysiology.

Physiological reviews·2014
Same author

Regulation of alternative VEGF-A mRNA splicing is a therapeutic target for analgesia.

Neurobiology of disease·2014
Same author

Transient receptor potential ankyrin 1: emerging pharmacology and indications for cardiovascular biology.

Acta physiologica (Oxford, England)·2010
Same author

A role for the medial preoptic area in CGRP-induced suppression of pulsatile LH secretion in the female rat.

Stress (Amsterdam, Netherlands)·2008
Same journal

Protein acetylation modification in tissue fibrosis: Opportunities and challenges.

Pharmacology & therapeutics·2026
Same journal

Nipocalimab and other FcRn blockers in neuromuscular disorders.

Pharmacology & therapeutics·2026
Same journal

C26:0-lysophosphatidylcholine in X-linked adrenoleukodystrophy.

Pharmacology & therapeutics·2026
Same journal

The CircRNA/miRNA axis in breast cancer: From molecular mechanisms to clinical translation.

Pharmacology & therapeutics·2026
Same journal

Glymphatic-meningeal lymphatic dysfunction in epilepsy: novel mechanistic insights and therapeutic avenues.

Pharmacology & therapeutics·2026
Same journal

The neurovascular unit under siege: Molecular mechanisms and potential drug target for cerebral edema.

Pharmacology & therapeutics·2026
See all related articles

Area of Science:

  • Biochemistry
  • Immunology
  • Pharmacology

Background:

  • Leukotrienes are synthesized from essential fatty acids by the 5-lipoxygenase enzyme.
  • Four-series leukotrienes, particularly those from arachidonic acid, are well-studied.
  • Leukotriene B4 attracts leukocytes and increases microvascular permeability; Leukotrienes C4, D4, and E4 constrict airways and affect vascular tone/permeability.

Purpose of the Study:

  • To review the role of leukotrienes in inflammatory conditions.
  • To highlight the therapeutic potential of leukotriene inhibitors.

Main Methods:

  • Literature review of leukotriene synthesis, function, and involvement in disease.
  • Discussion of current drug development targeting leukotriene pathways.

Related Experiment Videos

Main Results:

  • Leukotrienes are implicated in inflammatory diseases such as psoriasis, asthma, rheumatoid arthritis, and myocardial infarction.
  • Leukotriene B4 is a potent chemotactic agent and mediator of vascular permeability.
  • Leukotrienes C4, D4, and E4 are significant bronchoconstrictors and regulators of microvascular tone.

Conclusions:

  • Leukotrienes are key mediators in various human inflammatory conditions.
  • Drugs targeting leukotriene generation and action are promising anti-inflammatory agents currently in clinical trials.